Logical Therapeutics Lands $16,900,000 Series C Funding
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=e844d621-62d7-47df-aa6b-00f7e871134d&Preview=1 -
Date
5/27/2010 -
Company Name
Logical Therapeutics -
Mailing Address
300 Second Avenue Waltham, MA 02451 -
Company Description
The Company is developing medicines to treat diseases that are associated with poorly controlled or excessive inflammation. -
Website
http://www.logicaltherapeutics.com -
Transaction Type
Venture Equity -
Transaction Amount
$16,900,000 -
Transaction Round
Series C -
Proceeds Purposes
The Series C financing round is expected to provide sufficient capital to advance the Company’s development program through further clinical and non-clinical activities necessary for registration. The Company intends to seek a business partner prior to commercialization. -
M&A Terms
-
Venture Investor
SV Life Sciences -
Venture Investor
Burrill & Company -
Venture Investor
Novo A/S -
Venture Investor
Novitas Capital
